Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
NYSE-listed (LUV) US low-cost carrier at $26.4B revenue in strategic transition — eliminating open seating under Elliott activist pressure; Boeing 737 fleet competing with Delta and United for domestic leisure travel.
Southwest Airlines is a Dallas, Texas-based low-cost carrier — listed on NYSE (NYSE: LUV) — operating a point-to-point domestic US network with 817+ Boeing 737 aircraft to 121 airports in the US, Mexico, and the Caribbean, generating $26.4 billion in revenue in fiscal year 2024 and carrying 131 million passengers annually. Founded in 1967 by Herb Kelleher and Rollin King with the principle of democratizing air travel, Southwest built its model around operational simplicity: one aircraft type (Boeing 737), no assigned seating, no baggage fees (first two checked bags free), no change fees, and direct routes without hub connections.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.